Literature DB >> 7564108

Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells.

R J Quigg1, B P Morgan, V M Holers, S Adler, A E Sneed, C F Lo.   

Abstract

The complement regulators, decay accelerating factor, membrane cofactor protein, and CD59 are present in human glomeruli. Crry is the rodent analogue to the former two proteins. In this study, we examined complement regulation in cultured rat glomerular endothelial cells (GEnC) and mesangial cells (MES). Immunoprecipitation of 125I-labeled membrane proteins and Western blotting studies were performed with anti-Crry and anti-CD59. In both GEnC and MES, Crry was present as 53, 65, and 78 kD proteins. The 20 kD CD59 was apparent in GEnC. CD59 was also present in MES, but in relatively smaller quantities. By Northern analyses, 1.8 kb CD59 mRNA was present in GEnC as well as in RNA from isolated rat glomeruli. mRNA for Crry was present in both GEnC and MES as 2.2 kb species. The functional significance of these proteins was evaluated next. Anti-Thy 1.1 IgG was used to activate the complement classical pathway in MES. To inhibit the function of the complement regulators, anti-CD59 and/or anti-Crry F(ab')2 antibodies were added with anti-Thy 1.1. Inhibition of Crry function led to enhanced cytotoxicity, while there was no effect when CD59 function was inhibited. The complement alternative pathway was studied by adding complement in Mg-EGTA buffer. Inhibition of Crry led to productive alternative pathway activation, which was accentuated by anti-CD59 when Crry was incompletely inhibited. Alternative pathway regulation was also evaluated in GEnC. Inhibition of CD59 function alone had no effect in GEnC, while inhibition of Crry led to significant cytotoxicity from alternative pathway activation. Under conditions in which Crry was inactive, inhibition of CD59 further enhanced cytotoxicity. Therefore, Crry is present in both GEnC and MES and restricts the complement alternative pathway in both cell types. Crry also regulates the classical pathway in MES. CD59 is present and functionally active in GEnC, while it appears to have a minor role in MES.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564108     DOI: 10.1038/ki.1995.309

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  Tissue distribution of the rat analogue of decay-accelerating factor.

Authors:  O B Spiller; S M Hanna; B P Morgan
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

2.  Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion.

Authors:  Joshua M Thurman; Danica Ljubanović; Pamela A Royer; Damian M Kraus; Hector Molina; Nicholas P Barry; Gregory Proctor; Moshe Levi; V Michael Holers
Journal:  J Clin Invest       Date:  2006-01-26       Impact factor: 14.808

3.  An allelic variant of Crry in the murine Sle1c lupus susceptibility interval is not impaired in its ability to regulate complement activation.

Authors:  Svetlana N Tchepeleva; Joshua M Thurman; Katherine Ruff; Stephen J Perkins; Laurence Morel; Susan A Boackle
Journal:  J Immunol       Date:  2010-07-21       Impact factor: 5.422

Review 4.  Complement regulation during pregnancy.

Authors:  Hector Molina
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Molecular characterization of rat Crry: widespread distribution of two alternative forms of Crry mRNA.

Authors:  R J Quigg; C F Lo; J J Alexander; A E Sneed; G Moxley
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells.

Authors:  Silvia Ehrlenbach; Alejandra Rosales; Wilfried Posch; Doris Wilflingseder; Martin Hermann; Jens Brockmeyer; Helge Karch; Simon C Satchell; Reinhard Würzner; Dorothea Orth-Höller
Journal:  Infect Immun       Date:  2013-05-20       Impact factor: 3.441

7.  MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy.

Authors:  Qiang Wang; Youli Wang; Andrew W Minto; Jinhua Wang; Qun Shi; Xinmin Li; Richard J Quigg
Journal:  FASEB J       Date:  2008-08-20       Impact factor: 5.191

8.  Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH.

Authors:  R Killick; T R Hughes; B P Morgan; S Lovestone
Journal:  Neurosci Lett       Date:  2012-11-12       Impact factor: 3.046

9.  Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis.

Authors:  B Schiller; C He; D J Salant; A Lim; J J Alexander; R J Quigg
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

10.  Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury.

Authors:  R J Quigg; C He; A Lim; D Berthiaume; J J Alexander; D Kraus; V M Holers
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.